Lord, Abbett & Co. LLC
- SEC CIK
- 0000728100
- Latest filing
- Aug 14, 2026
NGM holding history
NGM Biopharmaceuticals Inc in every 13F filed by Lord, Abbett & Co. LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NGM overviewAll 13F holders of NGMFull Q2 2026 holdings
- Shares (Q4 2022)
- 0
- Sold out in Q4 2022
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 6
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2022 | 0 | $0 | 0.0% | −132,426−100.0% | Sold out | Holders |
| Q3 2022 | 132,426 | $1.73M | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 132,426 | $1.70M | <0.1% | −800−0.6% | Reduced | Holders |
| Q1 2022 | 133,226 | $2.03M | <0.1% | −52,375−28.2% | Reduced | Holders |
| Q4 2021 | 185,601 | $3.29M | <0.1% | +200+0.1% | Added | Holders |
| Q3 2021 | 185,401 | $3.90M | <0.1% | −3,700−2.0% | Reduced | Holders |
| Q2 2021 | 189,101 | $3.73M | <0.1% | +189,101 | New | Holders |